<DOC>
	<DOC>NCT02421432</DOC>
	<brief_summary>The purpose of this study is evaluation of the safety and the efficacy of transanal total mesorectal excision in difficult case. Difficult case is defined as below; - If any one of the following (1 or 2 or 3) 1. BMI: 30 or more 2. Tumor size: more than 7cm in long diameter 3. CRM: mesorectal fascia involvement or less than 1 mm on MRI</brief_summary>
	<brief_title>Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases</brief_title>
	<detailed_description>Subjects will have their rectal cancer removed using a technique combining surgery through the anus and standard laparoscopy. Transanal visualization will be using endoscopy. At the end of the procedure, the rectum will be removed though the anus or ileostomy formation site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be created, which is standard of care following surgery for this type of cancer.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>age: 2080 years biopsyproven adenocarcinoma of the rectum clinical staging (c or yc): T03, N02, M0 Rectal cancer located 312 cm from the anal verge ECOG performance status: 2 or less If any one of the following (1 or 2 or 3) 1. BMI: 30 or more 2. Tumor size: more than 7cm in long diameter 3. CRM: mesorectal fascia involvement or less than 1 mm on MRI Synchronous colon cancer or other malignancy Obstructing rectal cancer Pregnant or breastfeeding Receiving any other study agents Fecal incontinence History of prior colorectal cancer or inflammatory bowel disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>trananal TME</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>difficult cases</keyword>
</DOC>